Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ViewPoint 6

K-Number: K241300 · 2024-07-02

Decision Date2024-07-02
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

ViewPoint 6 is the device name listed in this FDA 510(k) record. The listed applicant is Ge Healthcare GmbH. It received FDA 510(k) clearance on 2024-07-02 under 510(k) number K241300. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ViewPoint 6?

ViewPoint 6 is a medical device that received FDA 510(k) clearance on 2024-07-02. The listed applicant is Ge Healthcare GmbH. The 510(k) number is K241300.

When did ViewPoint 6 receive FDA 510(k) clearance?

ViewPoint 6 received FDA 510(k) clearance on 2024-07-02, under 510(k) number K241300.

Who is the listed applicant for ViewPoint 6?

The FDA 510(k) record lists Ge Healthcare GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ViewPoint 6?

The FDA product code for ViewPoint 6 is LLZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Ge Healthcare GmbH as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 58 devices →

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.